ID   KATO III human CLDN18.2
AC   CVCL_E8JK
SY   KATOIII-CLDN18.2
DR   KYinno; KC-1453
CC   Population: Japanese.
CC   Doubling time: ~30 hours (KYinno=KC-1453).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2039; CLDN18 (Note=Isoform A2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0371 ! KATO III
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//